![Camilla Simpson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Camilla V.
Simpson is the founder of Rare Strategic LLC, founded in 2019, serving as President & Managing Member.
Current jobs include Chief Executive Officer at Zehna Therapeutics, Inc. since 2021, Independent Director at Spruce Biosciences, Inc. since 2017, Director at Dyve Biosciences, Inc. since 2020, and Independent Director at GRI Bio, Inc. since 2023.
Former jobs include Director at Aristea Therapeutics, Inc., Director at Vallon Pharmaceuticals, Inc., Senior VP & Head-Product Portfolio Development at BioMarin Pharmaceutical, Inc. from 2017 to 2019, and VP-Regulatory Affairs & Business Development at Shire Pharmaceuticals, Inc. Education includes graduate studies at the University of London and undergraduate studies at Kingston University and National University of Ireland Galway.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
GRI BIO, INC. -.--% | 17/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 01/10/2017 |
| GRI BIO, INC. | Direttore/Membro del Consiglio | 24/04/2023 |
Rare Strategic LLC | Fondatore | 01/04/2019 |
Dyve Biosciences, Inc.
 Dyve Biosciences, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Direttore/Membro del Consiglio | 01/12/2020 |
Zehna Therapeutics, Inc.
 Zehna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops non-bactericidal inhibitors for cardiovascular and chronic kidney diseases | Amministratore Delegato | 01/04/2021 |
| Società | Posizione | Fine |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/04/2019 |
| GRI BIOPAR | Direttore/Membro del Consiglio | - |
Aristea Therapeutics, Inc.
 Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies to treat serious inflammatory diseases | Direttore/Membro del Consiglio | - |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Consigliere Generale | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kingston University
 Kingston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Spruce Biosciences, Inc.
 Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which develops novel therapies for endocrine diseases | Health Technology |
National University of Ireland Galway
 National University of Ireland Galway Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aristea Therapeutics, Inc.
Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies to treat serious inflammatory diseases | Health Technology |
Dyve Biosciences, Inc.
Dyve Biosciences, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Health Technology |
Rare Strategic LLC | |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
Zehna Therapeutics, Inc.
Zehna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops non-bactericidal inhibitors for cardiovascular and chronic kidney diseases | Health Technology |
GRI Bio, Inc.
 GRI Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of inflammatory, fibrotic and autoimmune diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
